Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Towards Medication Optimisation in the Last Phase of Life: iLIVE Medication Study

NCT04717882 is registered in ClinicalTrials.gov with Prof. dr. Stefan Sleijfer as lead sponsor.

NCT NCT04717882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04717882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Towards Medication Optimisation in the Last Phase of Life: iLIVE Medication Study
Lead sponsor
Prof. dr. Stefan Sleijfer
Phase
Not applicable
Overall status
Unknown status
Start date
January 15, 2021
Completion date
January 15, 2024
Enrollment
400 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

palliative care